Arcutis Biotherapeutics saw the highest growth of 0.99% in patent filings in April and 3.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Arcutis Biotherapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Arcutis Biotherapeutics has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 50% grants. The Australia(AU), United States(US), Israel(IL), and European Patent Office(EPO) patent Office are among the top ten patent offices where Arcutis Biotherapeutics is filings its patents. Among the top granted patent authorities, Arcutis Biotherapeutics has 50% of its grants in United States(US), 30% in Australia(AU) and 10% in Israel(IL).
AbbVie could be the strongest competitor for Arcutis Biotherapeutics
In terms of grant share, Arcutis Biotherapeutics stands in ninth position among its competitors. AbbVie and Arcutis Biotherapeutics secured the top positions according to recent patent publication data.
Patents related to addiction and rare diseases lead Arcutis Biotherapeutics's portfolio
Arcutis Biotherapeutics has the highest number of patents in addiction followed by, rare diseases. For addiction no patents were filed and 50% of patents were granted in Q2 2024.
Atopic dermatitis (atopic eczema) related patents lead Arcutis Biotherapeutics portfolio followed by psoriasis, and bacterial infections
Arcutis Biotherapeutics has highest number of patents in atopic dermatitis (atopic eczema) followed by psoriasis, bacterial infections, asthma, and chronic obstructive pulmonary disease (copd).
For comprehensive analysis of Arcutis Biotherapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
